Evidence map›Paper›PMID 41858986›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2026

Satisfaction and Visual Outcomes with a Non-Diffractive EDOF IOL in Post-Myopic LASIK and PRK Patients with High Corneal Spherical Aberration.

J Morgan Micheletti, Brad Hall

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J Morgan MichelettiBerkeley Eye Center, Houston, TX, USA.ORCID 0000-0002-3657-5573
Brad HallSengi, Penniac, NB, Canada.ORCID 0000-0002-4097-6310

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate patient satisfaction and visual outcomes with extended depth of focus (EDOF) intraocular lens (IOL) implantation in post myopic refractive surgery patients with high corneal spherical aberrations. Methods: This was a non-interventional, observational, ambispective, bilateral, single center multi-surgeon study. Patients had history of myopic LASIK or PRK, and relatively high corneal spherical aberrations, and were bilaterally implanted with Vivity or Vivity toric EDOF IOLs targeting emmetropia. Endpoints included monocular and binocular uncorrected and distance corrected visual acuities at distance (UDVA, CDVA), intermediate (UIVA, DCIVA; 66cm), and near (UNVA, DCNVA; 40cm), binocular defocus curve, and patient satisfaction (IOLSAT) and visual disturbance (QUVID) questionnaires. Results: A total of 20 subjects (40 eyes) completed the study. Mean binocular UDVA, UIVA, and UNVA were 0.02 ± 0.16 logMAR, 0.14 ± 0.13 logMAR, and 0.24 ± 0.14 logMAR, respectively. The percentages of eyes with mean residual spherical equivalent and residual astigmatism ≤0.50 D were 95% (38/40) and 98% (39/40), respectively. On the QUVID questionnaire, 0% (0/20), 5% (1/20), and 0% (0/20) of patients reported being "Bothered quite a bit" or "Bothered very much" by halo, starbursts, or glare, respectively. On the IOLSAT, patient reported spectacle use was "Never" or "Rarely" in 90% (18/20), 75% (15/20), and 30% (6/20) of patients at distance, intermediate, and near, respectively. Conclusion: Results suggest good visual outcomes at distance, intermediate and functional near vision and high patient satisfaction with Vivity and Vivity toric IOL implantation in post myopic refractive surgery patients with high corneal spherical aberrations.

Indexed as

cataract surgeryEDOFpost-refractiveVivity

Identifiers

PMID41858986
PMCPMC12998678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.